Details for New Drug Application (NDA): 011745
✉ Email this page to a colleague
NDA 011745 describes KONAKION, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the KONAKION profile page.
The generic ingredient in KONAKION is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
The generic ingredient in KONAKION is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
Summary for 011745
| Tradename: | KONAKION |
| Applicant: | Roche |
| Ingredient: | phytonadione |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/0.5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
